Fig. 1

Schematic illustration of the CKAAKN peptide-conjugated long-circulating nanoliposome (ORI@CPD-Lipo) for targeted delivery of oridonin to pancreatic cancer.

Schematic illustration of the CKAAKN peptide-conjugated long-circulating nanoliposome (ORI@CPD-Lipo) for targeted delivery of oridonin to pancreatic cancer.